Rabbit Recombinant Monoclonal PPB1 antibody. Carrier free. Suitable for IHC-P, WB and reacts with Human samples.
pH: 7.2 - 7.4
Constituents: PBS
IHC-P | ICC/IF | IP | Flow Cyt | WB | |
---|---|---|---|---|---|
Human | Tested | Not recommended | Not recommended | Not recommended | Tested |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info - | Notes ab199376 - Rabbit monoclonal IgG, is suitable for use as an isotype control with this antibody. Perform heat-mediated antigen retrieval before commencing with IHC staining protocol. |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info - | Notes - |
Select an associated product type
Alkaline phosphatase that can hydrolyze various phosphate compounds.
PLAP, ALPP, Alkaline phosphatase Regan isozyme, Placental alkaline phosphatase 1, PLAP-1
Rabbit Recombinant Monoclonal PPB1 antibody. Carrier free. Suitable for IHC-P, WB and reacts with Human samples.
pH: 7.2 - 7.4
Constituents: PBS
ab220315 is the carrier-free version of Anti-Placental alkaline phosphatase (PLAP) antibody [EPR6141] ab133602.
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species. Please contact us for more information.
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
This product is a recombinant monoclonal antibody, which offers several advantages including:
For more information, read more on recombinant antibodies.
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. The carrier-free buffer and high concentration allow for increased conjugation efficiency.
This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Placental alkaline phosphatase (PLAP) also known by names like alkaline phosphatase/PLAP protein or ALPP functions as an enzyme that removes phosphate groups from molecules. It typically appears in tissues such as the placenta and is known to be active during pregnancy. PLAP has a molecular mass of approximately 66 kDa. Normally found expressed in the placenta this enzyme shares similarities with other alkaline phosphatases but is distinct due to its specific expression and function during gestation.
PLAP shows importance in bone mineralization and fetal development. It participates in the hydrolysis of phosphate esters influencing nutrient availability and metabolism. PLAP is not a part of major protein complexes; however its enzymatic activity directly affects local phosphate concentrations which are critical for processes like bone formation and tissue regeneration during pregnancy.
PLAP expression and activity intersect significantly with phosphate metabolism and fetal development pathways. The alkaline phosphatase family plays central roles in these pathways and PLAP shares functions with other isoenzymes in the family such as the tissue nonspecific alkaline phosphatase. These enzymes regulate phosphate turnover and contribute to essential developmental processes.
PLAP connects primarily to certain types of cancers and gestational disorders. Elevated levels of PLAP link to testicular germ cell tumors and ovarian cancer where it serves as a biomarker. In gestational trophoblastic disease PLAP expression provides valuable diagnostic information. Interactions with proteins like hCG (human chorionic gonadotropin) also offer insights into potential disease mechanisms especially in reproductive health challenges.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
This data was developed using the same antibody clone in a different buffer formulation (Anti-Placental alkaline phosphatase (PLAP) antibody [EPR6141] ab133602).
Lanes 1-4: Merged signal (red and green). Green - Anti-Placental alkaline phosphatase (PLAP) antibody [EPR6141] ab133602 observed at 70 kDa. Red - loading control, Anti-GAPDH antibody [6C5] - Loading Control ab8245 observed at 37 kDa.
Anti-Placental alkaline phosphatase (PLAP) antibody [EPR6141] ab133602 Anti-Placental alkaline phosphatase (PLAP) antibody [EPR6141] was shown to specifically react with Placental alkaline phosphatase (PLAP) in wild-type HeLa cells. Loss of signal was observed when knockout cell line Human ALPP (PLAP) knockout HeLa cell line ab261763 (knockout cell lysate Human ALPP (PLAP) knockout HeLa cell lysate ab256836) was used. Wild-type and Placental alkaline phosphatase (PLAP) knockout samples were subjected to SDS-PAGE. Anti-Placental alkaline phosphatase (PLAP) antibody [EPR6141] ab133602 and Anti-GAPDH antibody [6C5] - Loading Control (Anti-GAPDH antibody [6C5] - Loading Control ab8245) were incubated overnight at 4°C at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed ab216776) secondary antibodies at 1 in 10000 dilution for 1 hour at room temperature before imaging.
All lanes: Western blot - Anti-Placental alkaline phosphatase (PLAP) antibody [EPR6141] (Anti-Placental alkaline phosphatase (PLAP) antibody [EPR6141] ab133602) at 1/1000 dilution
Lane 1: Wild-type HeLa cell lysate at 20 µg
Lane 2: ALPP knockout HeLa cell lysate at 20 µg
Lane 2: Western blot - Human ALPP (PLAP) knockout HeLa cell line (Human ALPP (PLAP) knockout HeLa cell line ab261763)
Lane 3: Human placenta tissue lysate at 20 µg
Lane 4: Human heart tissue lysate at 20 µg
Performed under reducing conditions.
Predicted band size: 58 kDa
Observed band size: 70 kDa
Immunohistochemical analysis of paraffin-embedded Human placenta tissue labelling Placental alkaline phosphatase (PLAP) with Anti-Placental alkaline phosphatase (PLAP) antibody [EPR6141] ab133602 at 1/250.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (Anti-Placental alkaline phosphatase (PLAP) antibody [EPR6141] ab133602).
Perform heat mediated antigen retrieval before commencing with IHC staining protocol.
Anti-Placental alkaline phosphatase (PLAP) antibody [EPR6141] ab133602 showing positive staining in Normal placenta tissue.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (Anti-Placental alkaline phosphatase (PLAP) antibody [EPR6141] ab133602).
Perform heat mediated antigen retrieval before commencing with IHC staining protocol.
Immunohistochemical analysis of paraffin-embedded Human dysgerminoma tissue labelling Placental alkaline phosphatase (PLAP) with Anti-Placental alkaline phosphatase (PLAP) antibody [EPR6141] ab133602 at 1/250.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (Anti-Placental alkaline phosphatase (PLAP) antibody [EPR6141] ab133602).
Perform heat mediated antigen retrieval before commencing with IHC staining protocol.
Anti-Placental alkaline phosphatase (PLAP) antibody [EPR6141] ab133602 showing negative staining in Normal brain tissue.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (Anti-Placental alkaline phosphatase (PLAP) antibody [EPR6141] ab133602).
Perform heat mediated antigen retrieval before commencing with IHC staining protocol.
Anti-Placental alkaline phosphatase (PLAP) antibody [EPR6141] ab133602 showing negative staining in Normal liver tissue.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (Anti-Placental alkaline phosphatase (PLAP) antibody [EPR6141] ab133602).
Perform heat mediated antigen retrieval before commencing with IHC staining protocol.
Anti-Placental alkaline phosphatase (PLAP) antibody [EPR6141] ab133602 showing positive staining in Seminoma tissue.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (Anti-Placental alkaline phosphatase (PLAP) antibody [EPR6141] ab133602).
Perform heat mediated antigen retrieval before commencing with IHC staining protocol.
Anti-Placental alkaline phosphatase (PLAP) antibody [EPR6141] ab133602 showing negative staining in Normal colon tissue.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (Anti-Placental alkaline phosphatase (PLAP) antibody [EPR6141] ab133602).
Perform heat mediated antigen retrieval before commencing with IHC staining protocol.
Anti-Placental alkaline phosphatase (PLAP) antibody [EPR6141] ab133602 showing negative staining in Normal tonsil tissue.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (Anti-Placental alkaline phosphatase (PLAP) antibody [EPR6141] ab133602).
Perform heat mediated antigen retrieval before commencing with IHC staining protocol.
We have systematically measured KD (the equilibrium dissociation constant between the antibody and its antigen), of more than 840 recombinant antibodies to assess not only their individual KD values but also to see the average affinity of antibody.
Based on the comparison with published literature values for mouse monoclonal antibodies, Recombinant antibodies appear to be on average 1-2 order of magnitude higher affinity.
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com